Open Beta
TREN
MetriLume
TREN

US marketsJAZZ

SEC-sourced researchBeta

JAZZ

Jazz Pharmaceuticals plc

Company comparison ↗

Data passport

CIK
0001232524
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
5/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 3,834,204,000.0000 USD; December 2024: 4,068,950,000.0000 USD; December 2025: 4,267,586,000.0000 USD4.3B USD0 USD0December 2023December 2024December 2025
JAZZ · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20233,834,204,000.0000Feb 24, 2026
December 20244,068,950,000.0000Feb 24, 2026
December 20254,267,586,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20254,267,586,000.0000-356,148,000.00001,355,773,000.000011,659,340,000.0000—Feb 24, 2026
December 20244,068,950,000.0000560,120,000.00001,395,908,000.000012,012,257,000.0000—Feb 24, 2026
December 20233,834,204,000.0000414,832,000.00001,092,007,000.0000——Feb 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$4.27BDecember 2025Feb 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$4.07BDecember 2024Feb 24, 202610-K
Net incomeNetIncomeLoss-$356.15MDecember 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$1.36BDecember 2025Feb 24, 202610-K
Total assetsAssets$11.66BDecember 2025Feb 24, 202610-K
Total liabilities————

New filings

Explore methodology ↗